Petrus Trust Company’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,973
Closed -$517K 662
2024
Q4
$517K Buy
27,973
+4,600
+20% +$89.8K 0.05% 199
2024
Q3
$508K Buy
23,373
+1,622
+7% +$36.3K 0.05% 212
2024
Q2
$427K Hold
21,751
0.04% 290
2024
Q1
$472K Sell
21,751
-2,700
-11% -$67.1K 0.04% 234
2023
Q4
$707K Buy
24,451
+7,053
+41% +$189K 0.07% 110
2023
Q3
$465K Buy
+17,398
New +$594K 0.05% 205
2023
Q2
Sell
-7,212
Closed -$225K 641
2023
Q1
$225K Hold
7,212
0.03% 436
2022
Q4
$215K Buy
+7,212
New +$258K 0.03% 401

Other funds holding FLGT

Petrus Trust Company's FLGT Position: Q1 2025 in Review

Petrus Trust Company sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 27,973 shares — an estimated $517K sold.

Petrus Trust Company first reported a position in FLGT in Q4 2022 and held it in 8 quarters. The position peaked at $707K in Q4 2023. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Petrus Trust Company reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Petrus Trust Company sold 27,973 Fulgent Genetics shares in Q1 2025, an estimated $517K.
  • Petrus Trust Company first reported a position in Fulgent Genetics in Q4 2022 and held it in 8 quarters.
  • Petrus Trust Company's Fulgent Genetics position peaked at $707K in Q4 2023.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Petrus Trust Company's 13F filing for Q1 2025, filed 15 May 2025.